Insufficient scRNA-seq data for expression of AEN at single-cell level.
Insufficient scRNA-seq data for expression of AEN at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1803.57 | 328 / 328 | 100% | 17.38 | 178 / 178 |
thymus | 100% | 1768.25 | 652 / 653 | 100% | 20.95 | 604 / 605 |
stomach | 100% | 1561.83 | 359 / 359 | 100% | 21.32 | 285 / 286 |
bladder | 100% | 1571.48 | 21 / 21 | 99% | 18.02 | 501 / 504 |
uterus | 100% | 1240.89 | 170 / 170 | 99% | 19.11 | 456 / 459 |
skin | 99% | 1920.08 | 1797 / 1809 | 100% | 40.32 | 472 / 472 |
kidney | 100% | 989.74 | 89 / 89 | 99% | 19.45 | 895 / 901 |
intestine | 100% | 1327.86 | 965 / 966 | 99% | 25.92 | 524 / 527 |
lung | 99% | 1598.95 | 574 / 578 | 100% | 17.11 | 1155 / 1155 |
esophagus | 100% | 1302.73 | 1442 / 1445 | 99% | 17.18 | 182 / 183 |
breast | 100% | 989.58 | 458 / 459 | 99% | 16.78 | 1112 / 1118 |
prostate | 100% | 2017.31 | 245 / 245 | 99% | 17.32 | 497 / 502 |
adrenal gland | 100% | 1709.38 | 258 / 258 | 97% | 25.51 | 224 / 230 |
liver | 98% | 1107.05 | 222 / 226 | 96% | 13.52 | 388 / 406 |
brain | 91% | 554.48 | 2417 / 2642 | 95% | 17.19 | 671 / 705 |
ovary | 99% | 1154.25 | 179 / 180 | 81% | 6.69 | 347 / 430 |
lymph node | 0% | 0 | 0 / 0 | 100% | 44.70 | 29 / 29 |
spleen | 100% | 2398.09 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.04 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.14 | 1 / 1 |
adipose | 100% | 1076.99 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1211.14 | 1328 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 25.65 | 79 / 80 |
muscle | 92% | 1314.57 | 737 / 803 | 0% | 0 | 0 / 0 |
heart | 92% | 600.77 | 789 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 92% | 1561.69 | 851 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042771 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_0006259 | Biological process | DNA metabolic process |
GO_0010212 | Biological process | response to ionizing radiation |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005634 | Cellular component | nucleus |
GO_0004529 | Molecular function | DNA exonuclease activity |
GO_0004527 | Molecular function | exonuclease activity |
GO_0005515 | Molecular function | protein binding |
GO_0003676 | Molecular function | nucleic acid binding |
Gene name | AEN |
Protein name | Alternative protein AEN Apoptosis-enhancing nuclease (EC 3.1.-.-) (Interferon-stimulated 20 kDa exonuclease-like 1) Apoptosis enhancing nuclease |
Synonyms | SBBI58 ISG20L1 |
Description | FUNCTION: Exonuclease with activity against single- and double-stranded DNA and RNA. Mediates p53-induced apoptosis. When induced by p53 following DNA damage, digests double-stranded DNA to form single-stranded DNA and amplifies DNA damage signals, leading to enhancement of apoptosis. . |
Accessions | H0YMJ6 ENST00000332810.4 [Q8WTP8-1] Q8WTP8 L8EB49 ENST00000559528.1 |